s6y

Zeo ScientifiX, Inc.

Ticker
ZEOX
CIK
1557376
Industry
Biological Products, (No Diagnostic Substances)
Formerly
Organicell Regenerative Medicine, Inc., Biotech Products Services & Research, Inc., BESPOKE TRICYCLES INC

Financials 80

  1. 10-Q Quarterly Report for period ending Sep 30, 2026
  2. 10-KT Transition report pursuant to Rule 13a-10 or 15d-10 for period ending Jun 30, 2026
  3. NT 10-K Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT for period ending Jun 30, 2026
  4. NT 10-Q Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending Jul 31, 2026
  5. 10-Q Quarterly Report for period ending Apr 30, 2026
  6. 10-Q Quarterly Report for period ending Jan 31, 2026
  7. 10-K Annual Report for period ending Oct 31, 2025
  8. 10-Q Quarterly Report for period ending Jul 31, 2025
  9. 10-Q Quarterly Report for period ending Apr 30, 2025
  10. 10-Q Quarterly Report for period ending Jan 31, 2025

All 80 financials filings

News 155

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 155 news filings

Ownership 212

  1. 4 Statement of changes in beneficial ownership of securities
  2. 4 Statement of changes in beneficial ownership of securities
  3. 4 Statement of changes in beneficial ownership of securities
  4. 4 Statement of changes in beneficial ownership of securities
  5. 3 Initial statement of beneficial ownership of securities
  6. 4 Statement of changes in beneficial ownership of securities
  7. 4 Statement of changes in beneficial ownership of securities
  8. 4 Statement of changes in beneficial ownership of securities
  9. 4 Statement of changes in beneficial ownership of securities
  10. 4 Statement of changes in beneficial ownership of securities

All 212 ownership filings

Prospectus 13

  1. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  2. S-1/A General form of registration statement for all companies including face-amount certificate companies
  3. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  4. S-1 General form of registration statement for all companies including face-amount certificate companies
  5. S-1/A General form of registration statement for all companies including face-amount certificate companies
  6. S-1 General form of registration statement for all companies including face-amount certificate companies
  7. S-1/A General form of registration statement for all companies including face-amount certificate companies
  8. S-1/A General form of registration statement for all companies including face-amount certificate companies
  9. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  10. S-1 General form of registration statement for all companies including face-amount certificate companies

All 13 prospectus filings

Proxies 22

  1. DEF 14C Definitive information statements
  2. PRE 14C Preliminary information statement not related to a contested matter or merger/acquisition
  3. PRER14C Preliminary revised information statements
  4. PRE 14C Preliminary information statement not related to a contested matter or merger/acquisition
  5. DEF 14C Definitive information statements
  6. PRE 14C Preliminary information statement not related to a contested matter or merger/acquisition
  7. DEF 14C Definitive information statements
  8. PRER14C Preliminary revised information statements
  9. PRER14C Preliminary revised information statements
  10. PRE 14C Preliminary information statement not related to a contested matter or merger/acquisition

All 22 proxies filings

Other 37

  1. SCHEDULE 13D/A
  2. SCHEDULE 13D/A
  3. SCHEDULE 13G/A
  4. SCHEDULE 13D/A
  5. SCHEDULE 13D/A
  6. D Exempt (Private) Offering
  7. SCHEDULE 13D/A
  8. SCHEDULE 13D/A
  9. EFFECT Notice of Effectiveness
  10. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

All 37 other filings